Company
Precision Epigenomics
EPISEEK® Multi - Cancer Early Detection Blood Test
Also known as Precision Epigenomics Inc
- Business model
- B2B
- Legal name
- Precision Epigenomics Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Multi-cancer early detection through precision epigenomics.
Funding snapshot
- Total raised
- $1.4MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $265K2025-06-30
Funding rounds
- Round, 2025
- $265K2025-06-30, SEC form D sold, 5 investors
- Round, 2024
- $1.1M2024-03-18, SEC form D sold, 2 investors
Loading relationship preview